Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27650831 | 0.98 | SLC6A2 (0.33) | SLC6A3SLC6A2SLC6A4ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL27916528 | 0.98 | SLC6A2 (0.33) | SLC6A3SLC6A2SLC6A4ALDH1A1LMNA | |
| SCHEMBL5254752 | 0.94 | SLC6A3 (0.39) | SLC6A3SLC6A2SLC6A4DHFRALDH1A1 | |
| SCHEMBL17377297 | 0.77 | SLC6A3 (0.38) | SLC6A3SLC6A2SLC6A4DHFR | |
| SCHEMBL28094899 | 0.77 | — | — | |
| SCHEMBL27952382 | 0.77 | — | — | |
| SCHEMBL5535061 | 0.76 | — | — | |
| SCHEMBL23603002 | 0.75 | — | — | |
| SCHEMBL15818137 | 0.75 | — | — | |
| SCHEMBL4838694 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114409584-A | Preparation method of 1-methylpyrrolidine-2-formaldehyde | 重庆医药高等专科学校 | 2022-04-29 | — | — | CN | claimed |
| CN-114409584-A | Preparation method of 1-methylpyrrolidine-2-formaldehyde | 重庆医药高等专科学校 | 2022-04-29 | — | — | CN | disclosed |
| CN-114409584-A | Preparation method of 1-methylpyrrolidine-2-formaldehyde | 重庆医药高等专科学校 | 2022-04-29 | — | — | CN | disclosed |
| CN-105399698-A | Aromatic heterocyclic derivatives and applications of aromatic heterocyclic derivatives in medicines | GUANGDONG HEC PHARMACEUTICAL | 2016-03-16 | — | — | CN | disclosed |
| CN-101622258-B | Bicyclic oxomorpholine derivatives | EISAI R&D MAN CO LTD | 2012-06-13 | — | — | CN | disclosed |
| CN-1964970-B | Inhibitors of iap | NOVARTIS AG | 2011-08-03 | — | — | CN | disclosed |
| CN-102036984-A | Novel compounds as cannabinoid receptor ligands | ABBOTT LAB | 2011-04-27 | — | — | CN | disclosed |
| CN-1795193-B | N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors | NOVARTIS AG | 2010-08-18 | — | — | CN | disclosed |
| CN-101622258-A | Bicyclic oxomorpholine derivatives | EISAI R&D MAN CO LTD | 2010-01-06 | — | — | CN | disclosed |
| CN-1964970-A | Inhibitors of IAP | NOVARTIS AG (CH) | 2007-05-16 | — | — | CN | disclosed |
| CN-1795193-A | N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors | NOVARTIS AG (CH) | 2006-06-28 | — | — | CN | disclosed |
| CN-1671379-A | Hydrazinopyrazole derivatives and their use as therapeutic agents | QUADRA LOGIC TECH INC (CA) | 2005-09-21 | — | — | CN | disclosed |
| EP-1392315-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002100410-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | disclosed |